Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Tumour board–inspired AI system improves interpretation of oncology guidelines
A multi-agent artificial intelligence system designed to mimic the workflow of a multidisciplinary tumor board…
AI-predicted insulin resistance linked to risk of multiple cancers in large population study
Machine-learning–predicted insulin resistance was associated with increased risk of multiple cancer types in a large…
Smartwatch system may enable real-time pain monitoring in cancer care
A smartwatch-based monitoring system may enable more continuous remote monitoring of pain symptoms in patients…
Episode 1: Nothing to fear? Facing the challenge of fear of cancer recurrence
Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM for Series 2 of Supportive Care Matter. In this episode, Bogda chats to Professor Sophie Lebel and A/Professor Ben Smith about their work to alleviate Fear of Cancer Recurrence.
Enfortumab vedotin plus pembrolizumab in advanced bladder cancer: Hint of major added benefit
- EAU 2025: Sensory t-shirt collects patient data and enables shorter postoperative hospital stay
- ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years
- Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer
Cancer costs for Americans with private health insurance rose after the ACA rollout and fell for those with Medicaid
Olajumoke Olateju, University of Houston Low-income Americans ages 18 to 64 with cancer saved about US$1,250 per year on treatment…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.